CN106728081B - Preparation method of capsule for clearing away turbid and tonifying kidney - Google Patents
Preparation method of capsule for clearing away turbid and tonifying kidney Download PDFInfo
- Publication number
- CN106728081B CN106728081B CN201611228031.8A CN201611228031A CN106728081B CN 106728081 B CN106728081 B CN 106728081B CN 201611228031 A CN201611228031 A CN 201611228031A CN 106728081 B CN106728081 B CN 106728081B
- Authority
- CN
- China
- Prior art keywords
- extract
- preparing
- filtering
- filtrate
- concentrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 210000003734 kidney Anatomy 0.000 title claims abstract description 13
- 239000000284 extract Substances 0.000 claims abstract description 55
- 239000000843 powder Substances 0.000 claims abstract description 18
- 238000000605 extraction Methods 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract description 10
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 8
- 240000007371 Cuscuta campestris Species 0.000 claims abstract description 7
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 7
- 235000019206 astragalus extract Nutrition 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 7
- 229940119485 safflower extract Drugs 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 65
- 239000000706 filtrate Substances 0.000 claims description 30
- 210000000582 semen Anatomy 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 238000001914 filtration Methods 0.000 claims description 25
- 235000019441 ethanol Nutrition 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 19
- 238000010298 pulverizing process Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 241000190633 Cordyceps Species 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- 241000219061 Rheum Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 244000020518 Carthamus tinctorius Species 0.000 claims description 6
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims description 6
- 235000006533 astragalus Nutrition 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 240000004980 Rheum officinale Species 0.000 claims description 5
- 235000008081 Rheum officinale Nutrition 0.000 claims description 5
- 238000002137 ultrasound extraction Methods 0.000 claims description 5
- 241000045403 Astragalus propinquus Species 0.000 claims description 4
- 229920002472 Starch Polymers 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 230000007480 spreading Effects 0.000 claims description 3
- 238000003892 spreading Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 2
- 230000003179 granulation Effects 0.000 claims description 2
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 6
- 206010029164 Nephrotic syndrome Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 208000022461 Glomerular disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 231100000852 glomerular disease Toxicity 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007655 standard test method Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010013654 Drug abuse Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000003623 Hypoalbuminemia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 1
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 230000024924 glomerular filtration Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- -1 glycoside compounds Chemical class 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to the technical field of medicine extraction and preparation, and discloses a preparation method of a capsule for clearing away turbid heat and tonifying the kidney, which comprises the following steps: step 1) weighing raw materials, step 2) preparing fine powder of the cordyceps sinensis, step 3) preparing an astragalus extract, step 4) preparing a salvia miltiorrhiza extract, step 5) preparing a safflower extract, step 6) preparing a spina date seed and dodder seed rhubarb extract, and step 7) granulating. The cure rate of the capsule for clearing away turbid heat and tonifying the kidney prepared by the preparation method is obviously higher than that of the capsule for clearing away turbid heat and tonifying the kidney in the prior art, and the dosage is reduced by one fourth.
Description
Technical Field
The invention belongs to the technical field of medicine extraction and preparation, and particularly relates to a preparation method of a capsule for clearing away turbid and tonifying the kidney and a quality standard inspection method.
Background
Kidney disease has now become one of the major public health hazards. And the incidence of nephropathy in our country is also rising year after year due to irregular treatment, drug abuse and bad lifestyle. Nephrotic Syndrome (NS), abbreviated as renal heddle, refers to a group of syndromes mainly caused by various causes and mainly caused by glomerular diseases such as increase of glomerular basement membrane permeability and decrease of glomerular filtration rate. Nephrotic syndrome is not an independent disease, but a group of syndromes in glomerular disease. Typical symptoms are marked by massive proteinuria, hypoalbuminemia, high edema, hyperlipidemia. Can be caused by a plurality of kidney diseases, and is generally considered to be a cell immune disease in the medical field at present. Currently, the clinical routine treatment protocols are hormone therapy, anti-platelet aggregation therapy and the application of immunosuppressive agents.
The capsule for clearing turbid and tonifying kidney is a medicine for effectively treating nephrotic syndrome, has relatively simple raw material components, good effect and small toxic and side effect, and is popular with patients. The applicant finds that the extraction method of the raw materials of the medicine is relatively single in the pharmaceutical process, the same extraction process is adopted for various raw materials, the defect of loss of effective components exists, 4 granules are required to be taken for nephrotic syndrome every time, the dosage is too large, and the medicine is difficult to be accepted by part of patients and is easy to generate rejection emotion. Moreover, the improvement of the known medicine can save the early development cost of enterprises, and is a hot spot of enterprise research in recent years. Meanwhile, the quality control of the Qingzhuoyishen capsule is also a problem which needs to be taken into account in a GMP workshop. How to utilize raw materials to the maximum extent and improve the drug effect by improving the process is a problem which needs to be researched.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention provides a preparation method of the capsule for clearing away the turbid and tonifying the kidney, which is simple and feasible, extracts the effective components of the raw materials to the maximum extent, improves the drug effect and reduces the dosage of the drug.
The invention also provides a quality standard test method of the capsule for clearing away turbid and tonifying the kidney.
The invention is realized by the following technical scheme:
the preparation method of the capsule for clearing away turbid and tonifying the kidney comprises the following steps: step 1) weighing raw materials, step 2) preparing fine powder of the cordyceps sinensis, step 3) preparing an astragalus extract, step 4) preparing a salvia miltiorrhiza extract, step 5) preparing a safflower extract, step 6) preparing a spina date seed and dodder seed rhubarb extract, and step 7) granulating.
Specifically, the preparation method comprises the following steps: step 1) weighing raw materials: weighing the following raw materials for later use: 100g of cordyceps sinensis, 1400g of astragalus membranaceus, 280g of salvia miltiorrhiza, 280g of safflower, 280g of spina date seeds, 500g of semen cuscutae and 100g of rheum officinale;
step 2) preparing fine winter-spring cordyceps powder: pulverizing Cordyceps into fine powder;
step 3) preparing the astragalus extract: pulverizing radix astragali, sieving with 200 mesh sieve, placing in a container, adding 85% (v/v) ethanol twice the weight of radix astragali, stirring and extracting at 300rpm, controlling microwave power at 500W during extraction process, and extracting for 60 min; then placing at 4 ℃ for 12h, filtering, and keeping filter residues for later use; evaporating the filtrate under reduced pressure to recover ethanol, and concentrating the filtrate to obtain extract A with density of 1.3 g/ml;
adding water with twice weight of the filter residue, stirring uniformly, adding 0.5wt% of neutral protease (20 ten thousand U/g), performing enzymolysis at 37 ℃ for 120min, boiling for 5min, adding absolute ethyl alcohol with twice weight of the filter residue, stirring at 300rpm for 5min, standing for 12h, removing supernatant, collecting precipitate, dissolving in water, standing at-20 ℃ for 12h, centrifuging at 3000rpm for 3min, filtering to remove precipitate, and concentrating the filtrate under reduced pressure to obtain extract B with density of 1.3 g/ml; mixing the extract A and the extract B to obtain an astragalus extract;
step 4), preparing the salvia miltiorrhiza extract: pulverizing Saviae Miltiorrhizae radix, sieving with 200 mesh sieve, spreading into 3mm thick flat layer, irradiating under ultraviolet for 15min, collecting powder, placing in a container, adding water twice the weight of the powder, stirring at 300rpm, extracting, controlling microwave power at 700W during extraction, and extracting for 20 min; filtering, collecting filtrate, and concentrating to obtain extract of 1.3g/ml to obtain Saviae Miltiorrhizae radix extract;
step 5) preparing a safflower extract: putting Carthami flos into ultrasonic extraction tank, adding 75% ethanol with three times weight, controlling extraction temperature at 50 deg.C, performing ultrasonic extraction at 50KHz for 30min, filtering, collecting filtrate, and concentrating to obtain extract of 1.3g/ml to obtain Carthami flos extract;
step 6) preparing the spina date seed, the dodder seed and the rhubarb extract: mixing semen Ziziphi Spinosae and semen Cuscutae to obtain mixture of semen Ziziphi Spinosae and semen Cuscutae, decocting with water twice, adding 10 times of water, decocting for 2 hr, and filtering to obtain filtrate and residue; adding rhubarb into the medicine residues, then adding water which accounts for 5 times of the weight of the mixture of the spina date seeds and the south dodder seeds, decocting for 1.5 hours, and filtering to obtain filtrate; mixing the above two filtrates, concentrating into fluid extract with density of 1.1g/ml, cooling, adding ethanol to make ethanol content reach 70%, standing for 24 hr, filtering, collecting supernatant, recovering ethanol under reduced pressure, and concentrating to obtain extract with density of 1.3g/ml to obtain semen Ziziphi Spinosae and semen Cuscutae radix et rhizoma Rhei extract;
step 7) granulation: mixing the radix astragali extract obtained in step 3), the radix Salviae Miltiorrhizae extract obtained in step 4), the flos Carthami extract obtained in step 5), the semen Ziziphi Spinosae, semen Cuscutae, radix Et rhizoma Rhei extract obtained in step 6) and the Cordyceps fine powder obtained in step 2), drying, pulverizing, adding appropriate amount of starch, mixing, and making into capsule.
Preferably, the ultraviolet intensity is 3000uW/cm2。
Quality standard test method of the capsule preparation prepared by the preparation method.
The method should detect Cordyceps, protocatechuic aldehyde and radix et rhizoma Rhei, and the content of astragaloside IV in each granule should be not less than 0.30 mg.
Compared with the prior art, the invention has the following advantages and effects:
the effect of the clear turbid kidney-tonifying capsule preparation prepared by the invention is superior to that of the existing preparation, and the dosage is correspondingly reduced; the preparation method is simple and feasible, different traditional Chinese medicine components are treated by different technologies, the effective components of the raw materials are improved, the drug effect is increased, and the waste of the raw materials is reduced; the preparation method of the invention adopts smaller grain diameter to improve the leaching rate of the effective components of the astragalus, and can obtain glycoside compounds and polysaccharides by matching with a microwave alcohol extraction mode, thereby avoiding the loss of the components; when the salvia miltiorrhiza is extracted, the phenolic acid and ketone substances are easily decomposed by adopting a decoction mode, the extraction process of the salvia miltiorrhiza adopts ultraviolet rays with proper intensity, so that the dissolution rate of the effective ingredients is improved, and simultaneously, the microwave-assisted water extraction is adopted, so that the time is short, the extraction efficiency is improved, and the energy consumption is reduced; the chlorogenic acid and other acid substances and phenolic effective substances in the safflower are not easy to decoct, and the alcohol extraction method is adopted, so that the effective components are reserved.
Detailed Description
In order to make those skilled in the art better understand the technical solutions in the present application, the present invention will be described more clearly and completely below with reference to specific embodiments of the present application, and it is obvious that the described embodiments are only a part of the embodiments of the present application, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
The preparation method of the capsule for clearing away turbid and tonifying the kidney comprises the following steps:
1) weighing the following raw materials for later use: 100g of cordyceps sinensis, 1400g of astragalus membranaceus, 280g of salvia miltiorrhiza, 280g of safflower, 280g of spina date seeds, 500g of semen cuscutae and 100g of rheum officinale;
2) pulverizing Cordyceps into fine powder;
3) pulverizing radix astragali, sieving with 200 mesh sieve, placing in a container, adding 85% (v/v) ethanol twice the weight of radix astragali, stirring and extracting at 300rpm, controlling microwave power at 500W during extraction process, and extracting for 60 min; then placing at 4 ℃ for 12h, filtering, and keeping filter residues for later use; evaporating the filtrate under reduced pressure to recover ethanol, and concentrating the filtrate to obtain extract A with density of 1.3 g/ml; testing the content of astragaloside in the extract A to be more than 1.2mg/ml by adopting a high performance liquid chromatography;
adding water with twice weight of the filter residue, stirring uniformly, adding 0.5wt% of neutral protease (20 ten thousand U/g), performing enzymolysis at 37 ℃ for 120min, boiling for 5min, adding absolute ethyl alcohol with twice weight of the filter residue, stirring at 300rpm for 5min, standing for 12h, removing supernatant, collecting precipitate, dissolving in water, standing at-20 ℃ for 12h, centrifuging at 3000rpm for 3min, filtering to remove precipitate, and concentrating the filtrate under reduced pressure to obtain extract B with density of 1.3 g/ml; mixing the extract A and the extract B to obtain an astragalus extract; the molecular weight of the astragalus polysaccharide in the extract B is mostly distributed in 20000-40000 and accounts for more than 70 percent of the total sugar by adopting gel chromatography;
4) pulverizing Saviae Miltiorrhizae radix, sieving with 200 mesh sieve, spreading into 3mm thick flat layer, irradiating under ultraviolet for 15min, collecting powder, placing in a container, adding water twice the weight of the powder, stirring at 300rpm, extracting, controlling microwave power at 700W during extraction, and extracting for 20 min; filtering, collecting filtrate, and concentrating to obtain extract of 1.3g/ml to obtain Saviae Miltiorrhizae radix extract; the ultraviolet intensity is 3000uW/cm2;
5) Putting safflower into an ultrasonic extraction tank, adding 75% (volume parts) of ethanol with three times of weight, controlling the extraction temperature at 50 ℃, carrying out ultrasonic extraction for 30min at the frequency of 50KHz, filtering, collecting filtrate, and concentrating into 1.3g/ml extract to obtain safflower extract;
6) mixing semen Ziziphi Spinosae and semen Cuscutae to obtain mixture of semen Ziziphi Spinosae and semen Cuscutae, decocting with water twice, adding 10 times of water, decocting for 2 hr, and filtering to obtain filtrate and residue; adding rhubarb into the medicine residues, then adding water which accounts for 5 times of the weight of the mixture of the spina date seeds and the south dodder seeds, decocting for 1.5 hours, and filtering to obtain filtrate; mixing the above two filtrates, concentrating into fluid extract with density of 1.1g/ml, cooling, adding ethanol to make ethanol content reach 70% (volume fraction), standing for 24 hr, filtering, collecting supernatant, recovering ethanol under reduced pressure, concentrating into extract with density of 1.3g/ml to obtain semen Ziziphi Spinosae and semen Cuscutae radix et rhizoma Rhei extract;
7) mixing the radix astragali extract obtained in step 3), the radix salviae miltiorrhizae extract obtained in step 4), the safflower extract obtained in step 5), the spina date seed, semen cuscutae and rheum officinale extract obtained in step 6) and the cordyceps sinensis fine powder obtained in step 2), drying, crushing, adding a proper amount of starch, mixing uniformly, and encapsulating to prepare 1000 granules.
The usage and dosage are as follows: orally administered 3 capsules at a time, 0.45 g/capsule, 3 times a day.
Comparative example 1
A capsule for treating nephrotic syndrome is prepared from the following raw materials by weight: 100g of cordyceps sinensis, 1400g of astragalus membranaceus, 280g of salvia miltiorrhiza, 280g of safflower, 280g of spina date seeds, 500g of semen cuscutae and 100g of rheum officinale.
The preparation method of the capsule for clearing away turbid and tonifying the kidney comprises the following steps: weighing the raw materials according to weight for later use
(1) Pulverizing Cordyceps into fine powder;
(2) decocting radix astragali, Saviae Miltiorrhizae radix, Carthami flos and semen Ziziphi Spinosae in water twice, adding 10 times of water for the first time, decocting for 1.5 hr, and filtering to obtain filtrate and residue;
(3) adding rhubarb into the dregs obtained in the step (2), adding 8 times of water into the dregs, decocting the dregs for 1 hour, and filtering the decoction to obtain filtrate
(4) Mixing the filtrates of step (2) and step (3), concentrating into fluid extract with relative density of 1.14-1.16 (80-85 deg.C), cooling, adding ethanol to make ethanol content reach 70% (volume fraction), standing for 24 hr, filtering, collecting supernatant, and recovering ethanol.
(5) Decocting semen Cuscutae in water twice, adding 10 times of water for the first time, decocting for 1.5 hr, filtering to obtain filtrate and residue, decocting the residue in 8 times of water for 1 hr, and mixing the filtrates.
(6) And (3) combining the filtrate obtained in the step (5) and the supernatant obtained in the step (4), concentrating the mixture to thick paste with the relative density of 1.30-1.35(80-85 ℃), adding the fine powder prepared in the step (1), uniformly mixing, drying, crushing, adding a proper amount of starch, uniformly mixing, and encapsulating to prepare 1000 capsules.
The usage and dosage are as follows: orally administered 4 capsules at a time, 0.45 g/capsule, 3 times a day.
Example 2
Quality standards and inspection methods for the finished product prepared in example 1:
example 3
Animal safety test
40 healthy Kunming strain mice with the male and female halves and the body weight of 18.9 +/-2.3 g are randomly divided into two groups, wherein each group has the male and female halves, 20 of the mice are control groups, and normal water is filled in the control groups; in addition, 20 mice were administered with the drug prepared by the preparation method of example 1 at a dose of 2 mg/mouse three times a day, and acute toxicity experiments using the mice showed that: compared with a control group, the mice have no obvious difference after administration, and the mice have normal general condition, food intake, water drinking and weight increase after continuous observation for two weeks in experiments. Within two weeks after administration, no animal death is found, which indicates that the medicine has low acute toxicity and safe clinical administration.
Example 4
Clinical data
Selecting 2015 3-2016 9-month-old 108 patients admitted to the hospital, wherein 61 men and 47 women are in the group, the age is 32-73 years, and the average age is 43.1 years; the course of the disease is 2 months to 28 months, patients are randomly divided into 2 groups, 54 persons in example 1 group, and 54 persons in control 1 group. Inclusion criteria and therapeutic efficacy criteria reference CN 103638135A:
the treatment method comprises the following steps:
example 1 group: the medicine prepared in example 1 is taken 3 times a day 3 times, 4 weeks are a treatment course, and 2 treatment courses are treated.
Control example 1 group: the medicines prepared in the group of the control example 1 were taken 4 capsules at a time, 3 times a day, 4 weeks as a treatment course, and 2 treatment courses were performed.
The therapeutic effects are shown in the following table 2:
TABLE 2
Group of | Cure of disease | Improvement of life | Not cured | Cure rate |
EXAMPLE 1 group | 41 | 11 | 2 | 75.92% |
Comparative example 1 group | 30 | 18 | 6 | 55.56% |
And (4) conclusion: the cure rate of the composition of example 1 is significantly higher than that of the composition of control 1, and the dosage is reduced by one fourth.
Finally, it is also noted that the above-mentioned lists merely illustrate a few specific embodiments of the invention. It is obvious that the invention is not limited to the above embodiments, but that many variations are possible. All modifications which can be derived or suggested by a person skilled in the art from the disclosure of the present invention are to be considered within the scope of the invention.
Claims (2)
1. The preparation method of the capsule for clearing away turbid and tonifying the kidney comprises the following steps:
step 1) weighing raw materials: 100g of cordyceps sinensis, 1400g of astragalus membranaceus, 280g of salvia miltiorrhiza, 280g of safflower, 280g of spina date seeds, 500g of semen cuscutae and 100g of rheum officinale;
step 2) preparing fine winter-spring cordyceps powder: pulverizing Cordyceps into fine powder;
step 3) preparing the astragalus extract: pulverizing radix astragali, sieving with 200 mesh sieve, placing in a container, adding 85% v/v ethanol twice the weight of radix astragali, stirring and extracting at 300rpm, controlling microwave power at 500W during extraction process, and extracting for 60 min; then placing at 4 ℃ for 12h, filtering, and keeping filter residues for later use; evaporating the filtrate under reduced pressure to recover ethanol, and concentrating the filtrate to obtain extract A with density of 1.3 g/ml;
adding water with twice weight of the filter residue, stirring uniformly, adding 0.5wt% of neutral protease, performing enzymolysis at 37 ℃ for 120min, boiling for 5min, adding absolute ethyl alcohol with twice weight of the filter residue, stirring at 300rpm for 5min, standing for 12h, removing supernatant, collecting precipitate, dissolving with water, standing at-20 ℃ for 12h, centrifuging at 3000rpm for 3min, filtering to remove precipitate, and concentrating the filtrate under reduced pressure to obtain extract B with density of 1.3 g/ml; mixing the extract A and the extract B to obtain an astragalus extract;
step 4), preparing the salvia miltiorrhiza extract: pulverizing Saviae Miltiorrhizae radix, sieving with 200 mesh sieve, spreading into 3mm thick flat layer, irradiating under ultraviolet for 15min, collecting powder, placing in a container, adding water twice the weight of the powder, stirring at 300rpm, extracting, controlling microwave power at 700W during extraction, and extracting for 20 min; filtering, collecting filtrate, and concentrating to obtain extract of 1.3g/ml to obtain Saviae Miltiorrhizae radix extract;
step 5) preparing a safflower extract: putting Carthami flos into ultrasonic extraction tank, adding 75% ethanol with three times weight, ultrasonic extracting at 50 deg.C for 30min, filtering, collecting filtrate, and concentrating to obtain extract of 1.3g/ml to obtain Carthami flos extract;
step 6) preparing the spina date seed, the dodder seed and the rhubarb extract: mixing semen Ziziphi Spinosae and semen Cuscutae to obtain mixture of semen Ziziphi Spinosae and semen Cuscutae, decocting with water twice, adding 10 times of water, decocting for 2 hr, and filtering to obtain filtrate and residue; adding rhubarb into the medicine residues, then adding water which accounts for 5 times of the weight of the mixture of the spina date seeds and the south dodder seeds, decocting for 1.5 hours, and filtering to obtain filtrate; mixing the above two filtrates, concentrating into fluid extract with density of 1.1g/ml, cooling, adding ethanol, standing for 24 hr, filtering, collecting supernatant, recovering ethanol under reduced pressure, and concentrating into extract with density of 1.3g/ml to obtain semen Ziziphi Spinosae and semen Cuscutae radix et rhizoma Rhei extract;
step 7) granulation: mixing the radix astragali extract obtained in step 3), the radix Salviae Miltiorrhizae extract obtained in step 4), the flos Carthami extract obtained in step 5), the semen Ziziphi Spinosae, semen Cuscutae, radix Et rhizoma Rhei extract obtained in step 6) and the Cordyceps fine powder obtained in step 2), drying, pulverizing, adding appropriate amount of starch, mixing, and making into capsule.
2. The method according to claim 1, wherein the ultraviolet intensity is 3000uW/cm2。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611228031.8A CN106728081B (en) | 2016-12-27 | 2016-12-27 | Preparation method of capsule for clearing away turbid and tonifying kidney |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611228031.8A CN106728081B (en) | 2016-12-27 | 2016-12-27 | Preparation method of capsule for clearing away turbid and tonifying kidney |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106728081A CN106728081A (en) | 2017-05-31 |
CN106728081B true CN106728081B (en) | 2020-06-19 |
Family
ID=58921722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611228031.8A Active CN106728081B (en) | 2016-12-27 | 2016-12-27 | Preparation method of capsule for clearing away turbid and tonifying kidney |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106728081B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112168804A (en) * | 2020-11-04 | 2021-01-05 | 翔宇药业股份有限公司 | Preparation of kidney-tonifying capsule and quality standard test method |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446567A (en) * | 2013-08-30 | 2013-12-18 | 林凡友 | Premenstrual ease pharmaceutical composition and preparation technique thereof |
CN103638135A (en) * | 2013-12-22 | 2014-03-19 | 林凡友 | Capsule for clearing away turbid and tonifying kidneys |
-
2016
- 2016-12-27 CN CN201611228031.8A patent/CN106728081B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103446567A (en) * | 2013-08-30 | 2013-12-18 | 林凡友 | Premenstrual ease pharmaceutical composition and preparation technique thereof |
CN103638135A (en) * | 2013-12-22 | 2014-03-19 | 林凡友 | Capsule for clearing away turbid and tonifying kidneys |
Also Published As
Publication number | Publication date |
---|---|
CN106728081A (en) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108126026B (en) | Preparation method of cordyceps sinensis, astragalus and ginseng capsules | |
CN105125689B (en) | A kind of lavipeditum powder containing the FUKE QIANJIN PIAN dregs of a decoction and preparation method thereof | |
CN102552670A (en) | Preparation method for oral liquid capable of clearing heat and removing toxicity | |
CN102319357B (en) | Lipid-lowering dispersible tablets and preparation technology thereof | |
CN106729406B (en) | Preparation method of premenstrual ease preparation | |
CN106728081B (en) | Preparation method of capsule for clearing away turbid and tonifying kidney | |
CN102552527B (en) | Traditional Chinese medicine composition used for treating diabetic complications and reducing blood sugar and preparation method thereof | |
CN106266949A (en) | A kind of compound Chinese medicinal preparation and its preparation method and application | |
CN103055024B (en) | Fresh rehmannia powder for treating cancerous fever | |
CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
CN108126025A (en) | The preparation process of pure and impure kidney-tonifying capsule | |
CN106728079B (en) | Method for producing capsule preparation of Chinese caterpillar fungus, astragalus and ginseng | |
CN106491747B (en) | Preparation of cordyceps sinensis-astragalus-ginseng capsule and quality standard detection method | |
CN103638149B (en) | Traditional Chinese medicine composition for treating rectal cancer | |
CN102716423A (en) | Ruhesanjie capsule used for curing mammary hyperplasia diseases of women and preparation method thereof | |
CN106728080B (en) | Preparation process of compound medicine for treating chronic nephritis | |
CN101850009B (en) | Jinwei calculus-eliminating preparation and preparation method thereof | |
CN1176794A (en) | Medicine for treating masculine sterility | |
CN104001041A (en) | Traditional Chinese medicine for treating cerebral infarction | |
CN104840703A (en) | Medicine preparation for treating breast cancer | |
CN102512596A (en) | Traditional Chinese medicine for treating allergic purpura | |
CN1679650A (en) | Preparation of Fuyankang for gynecopathy | |
CN106334140A (en) | Traditional Chinese medicine composition and preparation method thereof | |
CN105213537A (en) | A kind of pharmaceutical composition for the treatment of congestive heart failure | |
CN1947779A (en) | Traditional Chinese medicine granules for treating infantile cough and its prepn. method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |